Cofoe Medical Technology Co.Ltd.
Cofoe Medical Technology Co.,Ltd. manufactures and sells professional household medical devices in China. It offers blood pressure monitors, nebulizers, thermometers, fingertip pulse oximeters, oxygen concentrators, fetal doppler, and CPAP and BPAP devices; in vitro diagnostic products, including glucose meters, HCG test kits, H.Pylori, UTM, DNA/RNA extraction reagents, and respiratory tract infe… Read more
Cofoe Medical Technology Co.Ltd. - Asset Resilience Ratio
Cofoe Medical Technology Co.Ltd. (301087) has an Asset Resilience Ratio of 18.32% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how Cofoe Medical Technology Co.Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Cofoe Medical Technology Co.Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.16 Billion | 18.32% |
| Total Liquid Assets | CN¥1.16 Billion | 18.32% |
Asset Resilience Insights
- Good Liquidity Position: Cofoe Medical Technology Co.Ltd. maintains a healthy 18.32% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Cofoe Medical Technology Co.Ltd. Industry Peers by Asset Resilience Ratio
Compare Cofoe Medical Technology Co.Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Cofoe Medical Technology Co.Ltd. (2021–2024)
The table below shows the annual Asset Resilience Ratio data for Cofoe Medical Technology Co.Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 21.13% | CN¥1.36 Billion | CN¥6.42 Billion | +7.50pp |
| 2023-12-31 | 13.63% | CN¥851.30 Million | CN¥6.24 Billion | -5.76pp |
| 2022-12-31 | 19.40% | CN¥1.24 Billion | CN¥6.41 Billion | -7.08pp |
| 2021-12-31 | 26.47% | CN¥1.54 Billion | CN¥5.81 Billion | -- |